Discounted Cash Flow (DCF) Analysis Levered
Inari Medical, Inc. (NARI)
$60.29
+1.32 (+2.24%)
All numbers are in Millions, Currency in USD
Free Cash Flow
Year A/P | 2018 Actual | 2019 Actual | 2020 Actual | 2021 Actual | 2022 Actual | 2023 Projected | 2024 Projected | 2025 Projected | 2026 Projected | 2027 Projected |
| Revenue | 6.83 | 51.13 | 139.67 | 276.98 | 383.47 | 1,302.49 | 4,424.02 | 15,026.55 | 51,038.93 | 173,357.98 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (%) | ||||||||||
| Operating Cash Flow | -10.89 | -4.94 | 1.91 | 25.49 | -13.97 | -422.59 | -1,435.36 | -4,875.32 | -16,559.43 | -56,245.47 |
| Operating Cash Flow (%) | ||||||||||
| Capital Expenditure | -0.75 | -3.14 | -5.46 | -13.64 | -9.95 | -74.52 | -253.11 | -859.71 | -2,920.08 | -9,918.30 |
| Capital Expenditure (%) | ||||||||||
| Free Cash Flow | -11.65 | -8.08 | -3.55 | 11.84 | -23.92 | -497.11 | -1,688.47 | -5,735.03 | -19,479.51 | -66,163.76 |
Weighted Average Cost Of Capital
| Share price | $ 60.29 |
|---|---|
| Beta | 1.118 |
| Diluted Shares Outstanding | 52.84 |
| Cost of Debt | |
| Tax Rate | -11.77 |
| After-tax Cost of Debt | 0.91% |
| Risk-Free Rate | |
| Market Risk Premium | |
| Cost of Equity | 8.977 |
| Total Debt | 32.29 |
| Total Equity | 3,185.58 |
| Total Capital | 3,217.87 |
| Debt Weighting | 1.00 |
| Equity Weighting | 99.00 |
| Wacc |
Build Up Free Cash Flow
Year A/P | 2018 Actual | 2019 Actual | 2020 Actual | 2021 Actual | 2022 Actual | 2023 Projected | 2024 Projected | 2025 Projected | 2026 Projected | 2027 Projected |
| Revenue | 6.83 | 51.13 | 139.67 | 276.98 | 383.47 | 1,302.49 | 4,424.02 | 15,026.55 | 51,038.93 | 173,357.98 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -10.89 | -4.94 | 1.91 | 25.49 | -13.97 | -422.59 | -1,435.36 | -4,875.32 | -16,559.43 | -56,245.47 |
| Capital Expenditure | -0.75 | -3.14 | -5.46 | -13.64 | -9.95 | -74.52 | -253.11 | -859.71 | -2,920.08 | -9,918.30 |
| Free Cash Flow | -11.65 | -8.08 | -3.55 | 11.84 | -23.92 | -497.11 | -1,688.47 | -5,735.03 | -19,479.51 | -66,163.76 |
| WACC | ||||||||||
| PV LFCF | -384.92 | -1,200.55 | -3,744.52 | -11,679.13 | -36,427.14 | |||||
| SUM PV LFCF | -63,371.19 |
Terminal Value
| Growth in perpetuity method: | |
|---|---|
| Long-term growth rate | |
| WACC (%) | 8.90 |
| Free cash flow (t + 1) | -67,487.04 |
| Terminal Value | -978,073.04 |
| Present Value of Terminal Value | -638,604.37 |
Intrinsic Value
| Enterprise Value | -701,975.56 |
|---|---|
| Net Debt | -27.93 |
| Equity Value | -701,947.63 |
| Shares Outstanding | 52.84 |
| Equity Value Per Share | -13,284.98 |